全球脊髓灰质炎根除进展——2021年1月至2023年3月
本报告总结2021年1月1日至2023年3月31日全球脊髓灰质炎根除进展,更新既往报告。2022年阿富汗和巴基斯坦报告22例WPV1病例,较2021年5例增加;2022年cVDPV病例859例,较2021年698例增加23%;在已消除地区检测到脊髓灰质炎病毒,使2023年检测到最后病例的目标难以实现。
要点
- 2022年阿富汗和巴基斯坦报告22例WPV1病例,2021年为5例。
- 2022年cVDPV病例859例,较2021年698例增加23%。
- 在加拿大、以色列、英国和美国等已消除地区检测到cVDPV。
核心结论
- 当前全球脊髓灰质炎病毒传播的流行病学使2023年检测到最后WPV1和cVDPV病例的目标日期不太可能实现。
- 在既往已消除地区检测到脊髓灰质炎病毒(WPV1和cVDPV)突显了病毒传播至任何脊髓灰质炎疫苗接种不足地区的威胁。
研究设计与样本
- 本报告总结2021年1月1日至2023年3月31日全球脊髓灰质炎根除进展,并更新既往报告。
主要发现
- 2022年阿富汗和巴基斯坦报告22例WPV1病例,2021年为5例;截至2023年5月5日,2023年巴基斯坦报告1例WPV1病例。
- 马拉维官员确认1例2021年11月发病的瘫痪儿童WPV1病例,为2016年以来非洲大陆首次报告WPV1病例;邻国莫桑比克随后报告8例 genetically linked 病例。
- 2022年cVDPV病例共859例,较2021年698例增加23%。
- 在加拿大、以色列、英国和美国等长期已消除脊髓灰质炎病毒传播的地区检测到cVDPV。
- 多个国家发生多种脊髓灰质炎病毒型别共循环,包括刚果民主共和国、以色列、马拉维、莫桑比克、刚果共和国和也门。
临床怎么用
- 在传播地区应进一步加强大规模疫苗接种和监测,以阻断脊髓灰质炎病毒传播并终结儿童瘫痪性脊髓灰质炎的全球威胁。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Since the World Health Assembly established the Global Polio Eradication Initiative (GPEI) in 1988, two of the three wild poliovirus (WPV) serotypes (types 2 and 3) have been eradicated, and global WPV cases have decreased by more than 99.9%. Afghanistan and Pakistan remain the only countries where indigenous WPV type 1 (WPV1) transmission has not been interrupted. This report summarizes progress toward global polio eradication during January 1, 2021-March 31, 2023, and updates previous reports (1,2). In 2022, Afghanistan and Pakistan reported 22 WPV1 cases, compared with five in 2021; as of May 5, 2023, a single WPV1 case was reported in Pakistan in 2023. A WPV1 case was reported on the African continent for the first time since 2016, when officials in Malawi confirmed a WPV1 case in a child with paralysis onset in November 2021; neighboring Mozambique subsequently reported eight genetically linked cases. Outbreaks of polio caused by circulating vaccine-derived polioviruses (cVDPVs) can occur when oral poliovirus vaccine (OPV) strains circulate for a prolonged time in underimmunized populations, allowing reversion to neurovirulence (3). A total of 859 cVDPV cases occurred during 2022, an increase of 23% from 698 cases in 2021. cVDPVs were detected in areas where poliovirus transmission had long been eliminated (including in Canada, Israel, the United Kingdom, and the United States). In addition, cocirculation of multiple poliovirus types occurred in multiple countries globally (including Democratic Republic of the Congo [DRC], Israel, Malawi, Mozambique, Republic of the Congo, and Yemen). The 2022-2026 GPEI strategic plan targeted the goal of detecting the last cases of WPV1 and cVDPV in 2023 (4). The current global epidemiology of poliovirus transmission makes the likelihood of meeting this target date unlikely. The detections of poliovirus (WPV1 and cVDPVs) in areas where it had been previously eliminated underscore the threat of continued poliovirus spread to any area where there is insufficient vaccination to poliovirus (3). Mass vaccination and surveillance should be further enhanced in areas of transmission to interrupt poliovirus transmission and to end the global threat of paralytic polio in children.
引用
- Lee SE, Greene SA, Burns CC, et al. Progress Toward Poliomyelitis Eradication - Worldwide, January 2021-March 2023. MMWR Morb Mortal Wkly Rep. 2023. PMID: 37167156. doi:10.15585/mmwr.mm7219a3
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。